https://cellcycleinhibitors.co....m/another-fight-gain
Although we formerly demonstrated that high-grade meningioma cells were extremely responsive to gemcitabine in vitro and in vivo, the root molecular mechanisms remain unidentified. We examined the roles of hENT1 (human equilibrative nucleoside transporter 1) and dCK (deoxycytidine kinase) in the gemcitabine susceptibility and growth of meningioma cells in vitro. Tissue samples from meningiomas (26 WHO grade I and 21 WHO level II/III meningiomas) had been immunohistochemically analyzed for hENT1 and
Like
Comment
Share
